Our Proprietary Allocetra Immunotherapy Platform
We are developing next-generation product candidates in some of the most important areas of cellular immunotherapy, including hematopoietic stem cell transplantation (HSCT), CAR T cell therapy, and autoimmune diseases. Our Allocetra solution is based on activation of well-established, well-characterized, natural biological pathways that are naturally utilized by the body as the standard protocol of action in cases of inflammation.
Allocetra presents a paradigm shift in the approach towards resolving imbalanced responses of the human immune system. Instead of attempting to TREAT a problem once it occurs — a point at which the patient may already be suffering or even in grave danger — Allocetra’s concept is to PREVENT the problem from the start and minimize the probability such a problem will occur.